Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
22-Dec-2021
Cholesterol-Lowering Program Pathway to Phase I
10-Dec-2021
Release of Securities from Escrow
19-Nov-2021
Nyrada Annual General Meeting Results
19-Nov-2021
Annual General Meeting Presentation
19-Nov-2021
Nyrada AGM 2021 Chairman's Address
26-Oct-2021
Nyrada Quarterly Activities Report & Appendix 4C
19-Oct-2021
2021 AGM Notice of Meeting and Proxy
19-Oct-2021
2021 AGM Letter to Shareholders and Proxy
13-Sep-2021
Presentation to ASX Small and Mid-Cap Conference
3-Sep-2021
Updated Share Trading Policy
1
2
3
4
5
6
7
Next
